HSP90AA1 Knockdown Enhances Doxorubicin Sensitivity by Promoting Immunogenic Cell Death-Related Signaling and Immune-Related Tumor Microenvironment Remodeling in Breast Cancer
Simple Summary Doxorubicin is an important chemotherapy drug for breast cancer, but treatment resistance and limited antitumor immune responses can reduce its effectiveness. In this study, we investigated HSP90AA1, a stress-related molecular chaperone that may help breast cancer cells adapt to chemotherapy. Using publi...